“The critical first step in achieving this goal is getting structured and unstructured data well organized and prepared for the successful application of our pattern-recognition technology and that’s what Adaptive does so well,” said Dr. Barnhill. "The combination of creating well structured data and then applying pattern-recognition analysis to that data is a winning strategy."A 2005 report by IBM (NYSE: IBM) titled, “Managing data in the 21st century,” states: “Costs associated with managing and storing the burgeoning amount of enterprise wide data continue to expand exponentially. Now, more than ever, companies need to analyze their ability to backup, recover and manage that data—which is now the key business asset.” A July 2010 Wall Street Journal article titled, “Big Data, Big Growth, Big M&A,” stated: “The big data problem is getting bigger. Every enterprise data center vendor, from Oracle Corp. (NasdaqGS: ORCL) to Hewlett Packard Co. (NYSE: HPQ) sees an opportunity in solving it.” About Health Discovery Corporation Health Discovery Corporation is a molecular diagnostics company that uses advanced mathematical techniques to analyze large amounts of data to uncover patterns that might otherwise be undetectable. It operates primarily in the emerging field of personalized medicine where such tools are critical to scientific discovery. Its primary business consists of licensing its intellectual property and developing its own product line of biomarker-based diagnostic tests that include human genes and genetic variations, as well as gene, protein, and metabolic expression differences and image analysis in digital pathology and radiology. For more information, see www.healthdiscoverycorp.com. About Adaptive, Inc. Founded in 2002, Adaptive is a transatlantic company with its U.S. headquarters in Aliso Viejo, California. Adaptive’s mission is to help complex organizations adapt and support the rapidly changing IT and business environments which are driven by the ever increasing demands of compliance, regulatory pressures and governance requirements. Adaptive enables companies faced with an explosion of the amount, complexity and importance of enterprise metadata to capture, analyze and manage this metadata on a single point of truth platform. Adaptive has developed and delivers its leading semantic metadata repository technology to large, complex organizations around the world.
Adaptive has developed and delivered a single, automated framework, The Adaptive Framework, for capturing, storing, integrating, analyzing, visualizing and sharing the knowledge about an organization’s strategies, processes, semantics, stewardship, technology and other resources. Adaptive’s fundamental object-oriented design and standards based openness ensures agility in response to business requirement change. Its web-based accessibility leveraging its advanced workflow capability ensures a global platform for knowledge-sharing and better decision-making. With compliance to industry standards, the Adaptive offerings leverages existing data sources to include business intelligence, legacy, databases, ETL and various semantic modeling technologies and links the semantic relationships between these silo data sources enabling enterprises a platform for proper data governance, stewardship and change management.Adaptive’s current clients include major financial and insurance institutions, as well as federal and foreign government agencies. For more information see www.adaptive.com. Forward-Looking Statements This document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, the accuracy of which is necessarily subject to risks and uncertainties, including, without limitation, statements regarding future performance, opportunities and investments, and anticipated results in general. From time to time the Company may make other forward-looking statements relating to other matters, including without limitation, commercialization plans and strategic partnerships. Actual results may differ materially due to a variety of factors, including, among other things, the acceptance of our approach to applying mathematics computer science and physics into the disciplines of biology, organic chemistry and medicine and our products and technologies associated with those approaches, the ability to develop or commercialize new drugs, therapies or other products based on our approaches, and other factors set forth from time to time in the Company’s Securities and Exchange Commission filings. All forward-looking statements and cautionary statements included in this document are made as of the date hereof based on information available to the Company as of the date hereof, and the Company assumes no obligation to update any forward-looking statement or cautionary statement.